PE/Cyanine7 anti-mouse CD64 (FcγRI) Antibody
- 产品名称:
- PE/Cyanine7 anti-mouse CD64 (FcγRI) Antibody
- 产品类别:
- 抗体
- 产品编号:
- 139313
- 产品应用:
- 139313
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- BALB/c mouse FcγRI-human IgG Fc fusion protein.
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography and conjugated with PE/Cyanine7 under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.5 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
The X54-5/7.1 antibody reacts with mouse strains carrying CD64a and b alleles but not CD64d. X54-5/7.1 recognizes a conformational determinant formed between domains 2 and 3. Additional reported application (for relevant formats) include: immunoprecipitation1, and spatial biology (IBEX)5,6. Clone X54-5/7.1 is not found to be useful for Western blots1.
- Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
- Application References
(PubMed link indicates BioLegend citation) -
- Tan PS, et al. 2003. J. Immunol. 170:2549. (IP)
- Ingersoll MA, et al. 2010. Blood 115:e10. (FC)
- Ozeri E, et al. 2012. J. Immunol. 189:146. PubMed
- Richardson ML, et al. 2014. PLoS Negl Trop Dis. 8:2825. PubMed
- Radtke?AJ,?et al.?2020.?Proc Natl Acad Sci U S A.?117:33455-65. (SB)?PubMed
- Radtke?AJ,?et al.?2022.?Nat Protoc.?17:378-401. (SB)?PubMed
- Product Citations
-
- Koyama M, et al. 2015. J Exp Med. 212: 1303 - 1321. PubMed
- Gallizioli M, et al. 2020. Cell Rep. 33:108291. PubMed
- Philpott J, et al. 2022. Immunohorizons. 6:366. PubMed
- Larson-Casey JL, et al. 2021. FASEB J. 35:e21675. PubMed
- B?ttcher JP, et al. 2018. Cell. 172:1022. PubMed
- Larsen SE, et al. 2021. Sci Rep. 11:9040. PubMed
- Atkin-Smith G, et al. 2017. Sci Rep. 7:39846. PubMed
- Webster HC, et al. 2020. J Immunol Methods. 112702:477. PubMed
- Mitsune A, et al. 2021. Respir Res. 22:232. PubMed
- Helm M, et al. 2022. Life (Basel). 12:. PubMed
- Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
- Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
- Chen L, et al. 2020. J Exp Med. 217:00:00. PubMed
- Affo S, et al. 2021. Cancer Cell. 39(6):866-882.e11. PubMed
- Fantauzzi MF, et al. 2021. ERJ Open Res. 7: . PubMed
- Hole CR, et al. 2019. Nat Commun. 10:2955. PubMed
- Freemerman AJ, et al. 2019. J Immunol. 202:1265. PubMed
- Smith AS, et al. 2022. J Immunother Cancer. 10:. PubMed
- Alikhanyan K, et al. 2021. Cancers (Basel). 13:. PubMed
- Progatzky F, et al. 2021. Nature. 599:125. PubMed
- Yadav P, et al. 2021. J Immunol. 206:2888. PubMed
- Liu CY, et al. 2020. Cell Rep. 33:108275. PubMed
- Brown CC, et al. 2020. Cell. 179(4):846-863.e24.. PubMed
- Wu Y, et al. 2021. PLoS Negl Trop Dis. 15:e0010050. PubMed
- Macdougall CE et al. 2018. Cell metabolism. 27(3):588-601 . PubMed
- Martínez‐López M et al. 2019. Immunity. 50(2):446-461 . PubMed
- Casulli J, et al. 2019. Nat Commun. 10:2121. PubMed
- Zheng J, et al. 2020. Nature. . PubMed
- Olson GS, et al. 2021. Cell Reports. 35(9):109195. PubMed
- Kaya B, et al. 2020. Cell Reports. 32(5):107979. PubMed
- Smith CA, et al. 2019. JCI Insight. 4. PubMed
- Luo J et al. 2018. Immunity. 49(1):107-119 . PubMed
- Maulloo CD, et al. 2021. Front Immunol. 12:714842. PubMed
- Larson-Casey JL, et al. 2021. J Biol Chem. :100810. PubMed
- Giampazolias E, et al. 2021. Cell. . PubMed
- Youshani AS, et al. 2019. J Neuroinflammation. 16:25. PubMed
- Murray MP, et al. 2022. Cell Rep. 38:110209. PubMed
- Chen F, et al. 2022. Cell Rep. 38:110215. PubMed
- Xu J, et al. 2020. Immunity. 53(2):371-383.e5. PubMed
- Birkl D, et al. 2019. FASEB J. 33:13632. PubMed
- Carlson PM, et al. 2021. J Immunol. 207:720. PubMed
- Wong NR, et al. 2021. Immunity. 54:2072. PubMed
- Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
- Choi J, et al. 2020. Cell Stem Cell. 27:366. PubMed
- Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
- Bosteels C, et al. 2020. Immunity. 52(6):1039-1056.e9.. PubMed
- Rochford I, et al. 2021. Am J Physiol Lung Cell Mol Physiol. 321:L686. PubMed
- Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
- Larson–Casey JL, et al. 2019. J Clin Invest. 129:4962. PubMed
- Wang L, et al. 2020. J Nanobiotechnology. 18:38. PubMed
- Rappe JCF, et al. 2021. J Exp Med. 218:. PubMed
- RRID
- AB_2563903 (BioLegend Cat. No. 139313) AB_2563904 (BioLegend Cat. No. 139314)
- Structure
- Ig superfamily, type I glycoprotein, 72 kD
- Distribution
-
Monocytes, macrophages, mast cells, dendritic cells
- Function
- Phagocytosis, ADCC
- Ligand/Receptor
- IgG
- Cell Type
- Dendritic cells, Macrophages, Mast cells, Monocytes
- Biology Area
- Immunology, Innate Immunity
- Molecular Family
- CD Molecules, Fc Receptors
- Gene ID
- 14129 View all products for this Gene ID
- UniProt
- View information about CD64 on UniProt.org